From: Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease
Patient group | OAS (%) in allergic group | OAS (%) in silver birch sensitised group |
---|---|---|
OFG alone | 23/52 (44%) | 19/39 (49%) |
OFG + CD | 2/20 (10%) | 2/10 (20%) |
Total | 25/ 72 (35%) | 21/49 (43%) |